$441.74
+13.40 (+3.13%)
At Close: Jun 04, 2026
Final Trades: Gilead, Vertex, Wynn & more
02:01pm, Thursday, 20'th Apr 2023
The "Halftime Report" traders give their top picks to watch for the second half.
Better Big Biotech Buy: Biogen vs. Vertex
02:00pm, Thursday, 20'th Apr 2023
Biogen and Vertex are both waiting on big regulatory decisions for potential products. The companies each bring in billions of dollars in revenue every year.
BMEZ: Attractive Discount On This Riskier Healthcare Fund
12:12pm, Thursday, 20'th Apr 2023
BMEZ: Attractive Discount On This Riskier Healthcare Fund.
Have $1,000? 2 Explosive Growth Stocks to Buy and Hold No Matter What the Market Does Next
10:15am, Thursday, 20'th Apr 2023
Long-term investors needn't fear the unpredictable highs and lows of the market. Vertex is the leader in cystic fibrosis treatment and is looking to broaden out its portfolio.
Why Vertex (VRTX) Could Beat Earnings Estimates Again
01:42pm, Tuesday, 18'th Apr 2023
Vertex (VRTX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Got $5,000? Buy and Hold These Fast-Growing Stocks for Years
09:45am, Tuesday, 18'th Apr 2023
Vertex stock could take off if a gene-editing therapy obtains approval this year. Shopify's stock has taken a beating, but it still has plenty of growth opportunities.
3 High-Growth Biotech Stocks Poised for Success in 2023
06:40am, Tuesday, 18'th Apr 2023
Many investors look for growth opportunities wherever they can find them. If that describes you, then there are some high-growth biotech stocks that could present an opportunity.
The Fed Thinks a Recession Is More Likely: Here Are 3 Great Stocks to Buy Now
05:52am, Tuesday, 18'th Apr 2023
Dollar General is arguably the ultimate recession-proof stock. Johnson & Johnson is a favorite safe-haven stock for investors during economic downturns.
Prediction: These Will Be 3 of the Biggest Monster Stocks of the Decade
05:50am, Monday, 17'th Apr 2023
MercadoLibre combines e-commerce, fintech, and emerging market opportunities in one fell swoop. The Trade Desk has a massive opportunity with the rapid growth in connected TV.
2 Nasdaq Growth Stocks That Are Screaming Buys in April
10:15am, Thursday, 13'th Apr 2023
Vertex Pharmaceuticals has a relatively safe top line, and more growth on the way. CRISPR Therapeutics is on track to start realizing revenue growth like wild.
Could This Move Make Vertex's Next Blockbuster Even Bigger?
05:30am, Wednesday, 12'th Apr 2023
Vertex Pharmaceuticals recently completed regulatory requests for its blood disorder candidate, exa-cel. Exa-cel has what it takes to become a blockbuster over time.
Vertex to Announce First Quarter 2023 Financial Results on May 1
08:05am, Monday, 10'th Apr 2023
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its first quarter 2023 financial results on Monday, May 1, 2023 after the financial markets close. The company w
My 5 Top Stocks to Buy in April
05:54am, Monday, 10'th Apr 2023
Two of these stocks have technology ties, one in cloud hosting and the other in adtech. Two are in the energy sector and offer great dividends plus solid growth prospects.
2 Winning Stocks That Could Turn $10,000 into $50,000 by 2030
06:30am, Sunday, 09'th Apr 2023
Even another market downturn could present opportunities for long-term investors. Vertex Pharmaceuticals isn't slowing down, but more growth opportunities could be on the near horizon.
3 No-Brainer Stocks to Buy in a New Bull Market
06:11am, Saturday, 08'th Apr 2023
Novo Nordisk has exceptional growth prospects with its diabetes and obesity drugs. Pfizer isn't getting the respect it deserves.
Sign In
Buy VRTX